Suppliers / Auro Peptides

Auro Peptides

India Updated 9 July 2026

Auro Peptides is an API manufacturer based in India. It holds 14 active US drug master files and 2 valid CEPs across a filed portfolio of 14 molecules. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 16 February 2024 as NAI. Customs aggregates show $545K of exports covering 98 molecules to 7 destinations in 2025.

14
active US DMFs
2
valid CEPs
2
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
2 of 2 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 16 February 2024 NAI US FDA
  • 2 September 2016 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Kandi Mandal, India Not on file
Sangareddy District, India 3010923869

What they file, and where

Molecule Regulators Docs
Desmopressin EDQM, US FDA 2
Octreotide EDQM, US FDA 2
Vasopressin SFDA (Saudi Arabia), US FDA 2
Degarelix US FDA 1
Etelcalcetide US FDA 1
Ganirelix US FDA 1
Glatiramer US FDA 1
Icatibant US FDA 1
Leuprolide US FDA 1
Linaclotide US FDA 1
Show all 14 molecules on file
Liraglutide US FDA 1
Plecanatide US FDA 1
Semaglutide US FDA 1
Teriparatide US FDA 1

Also appears on these molecule pages

Degarelix API Desmopressin API Etelcalcetide API Ganirelix API Glatiramer API Icatibant API Leuprolide API Linaclotide API Liraglutide API Octreotide API Plecanatide API Semaglutide API
Show 2 more molecule pages
Teriparatide API Vasopressin API

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA None 1

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $43 2
2025 Not reported $545K 7
2024 Not reported $407K 8
2023 Not reported $2.3M 9

Export figures are customs aggregates. We do not publish the identity of any buyer.

Questions about Auro Peptides

Does Auro Peptides hold a US DMF or a CEP?
Auro Peptides holds 14 active US drug master files and 2 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Auro Peptides FDA-registered?
One site operated by Auro Peptides carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Auro Peptides's last inspection go?
The most recent inspection on record closed on 16 February 2024 as NAI (No Action Indicated: nothing objectionable was found). 2 inspections are on file.
Where does Auro Peptides manufacture?
2 registered sites are on record, in India (Kandi Mandal and Sangareddy District). Every site is listed on this page with the register it came from.
What does Auro Peptides make?
14 molecules are on record against Auro Peptides, including Desmopressin, Octreotide, Vasopressin and Degarelix. Each links through to that molecule's full manufacturer list.
Which regulators recognise Auro Peptides's GMP?
Current GMP certificates are on record from US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Auro Peptides comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 16 February 2024.

Comparable suppliers

Hybio Pharmaceutical shares 11 molecules PolyPeptide shares 7 molecules Piramal Pharma shares 6 molecules ScinoPharm Taiwan shares 6 molecules Bcn Peptides shares 6 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts